Re-activation of bovine tuberculosis in a patient treated with infliximab

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 229-231

  Larsen, M V ^a   Sorensen I J ^a   Thomsen, V O ^b   Ravn, P ^c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diagnosis; Immunosuppression; Interferon release assays; Mycobacterium bovis; Tuberculosis; Tumour necrosis factor inhibitor

Indexed keywords

ETHAMBUTOL; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRIDOXINE; RIFAMPICIN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANAMNESIS; ARTICLE; ASCITES; BLOOD EXAMINATION; BOVINE TUBERCULOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; FEMALE; HUMAN; MYCOBACTERIUM BOVIS; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULIN TEST; DRUG ANTAGONISM; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PLEURA EFFUSION;

AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52749094807     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00125607     Document Type: Article

References (14)

1. Toussirot E, Wendling D. The use of TNF-α blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 2007; 8: 2089-2107.
2. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 2005; 60: 800-805.
3. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
4. Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A, et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 2005; 64: 1360-1361.
5. Efthimiou P, Sood S. QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis? Ann Rheum Dis 2007; 66: 276.
6. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945-950.
7. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases performance of a Mycobacterium tuberculosis antigen-specific interferon-γ assay. Ann Rheum Dis 2008; 67: 84-90.
8. Pratt A, Nicholl K, Kay L. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-α agents: the Newcastle (UK) experience. Rheumatology (Oxford) 2007; 46: 1035-1036.
9. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631-635.
10. Ravn P, Munk ME, Andersen AB, et al. Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis 2004; 36: 499-501.
11. Codeluppi M, Cocchi S, Guaraldi G, et al. Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant Proc 2006; 38: 1083-1085.
12. Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 2007; 55: 484-487.
13. Buddle BM, Parlane NA, Keen DL, et al. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol 1999; 6: 1-5.
14. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007; 9: 806-812.